Sakar Healthcare logo

Sakar Healthcare financials and balance sheet

NSE: SAKARPharmaceuticals & BiotechnologySmall Cap

Last close ₹889.80down ₹62.00 (6.51%)

Share price at the NSE close on 23 Oct 2026. Previous close ₹951.80.

52-week range of traded prices to 23 Oct 2026
₹352.00Low, 27 Oct 2025₹1,229.85High, 23 Sep 2026
Market cap
₹1,980 Cr1,357th largest listed
P/E
46.2
P/B
5.7
Dividend yield
Nonein the last 12 months
ROE
13.2%
ROCE
16.6%
Debt to equity
0.13
Volume, NSE
7,47,09017.5% delivered

10 years at a glance

Standalone: the listed company alone, without its subsidiaries. ₹ crore, years to March.Sakar Healthcare annual reports

Revenue, net profit and borrowings, ₹ crore

  • Revenue
  • Net profit
  • Borrowings
Peak revenue ₹252 Cr, year to Mar 2026

Operating and net margin, per cent

  • Operating margin
  • Net margin

Results for the year to Mar 2026

Standalone: the listed company alone, without its subsidiaries. ₹ crore.

From revenue to net profit

  1. Revenue252
  2. Materials and goods−123
  3. Employee costs−39
  4. Other expenses−21
  5. Operating profit69
  6. Depreciation−24
  7. Other income+2.3
  8. One-off items0.0
  9. Finance costs−7.9
  10. Profit before tax40
  11. Tax−9.3
  12. Net profit30

What the company owns

  • Plant, investments and other assets₹361 Cr
  • Inventory₹70 Cr
  • Receivables₹50 Cr
  • Cash and bank₹0 Cr

What pays for it: net worth and liabilities

  • Net worth₹325 Cr
  • Borrowings₹55 Cr
  • Owed to suppliers₹52 Cr
  • Other liabilities₹50 Cr

Profit and loss

Standalone, ₹ crore, years to March. No results on record for the year to Mar 2019.Sakar Healthcare quarterly results

₹ croreMar 2017Mar 2018Mar 2019Mar 2020Filed 24 AugMar 2021Filed 1 JunMar 2022Filed 21 MayMar 2023Filed 27 MayMar 2024Filed 21 MayMar 2025Filed 15 MayMar 2026Filed 12 May
Revenue from operations4453–8395128133153178252
3440–637299100115128183
Materials and goods bought2228–435174748482123
Employee costs67–12131517203239
Other expenses66–88910121421
Operating profit before depreciation1013–20232933385069
Operating margin23.0%23.7%–23.6%23.9%22.9%24.9%25.0%28.0%27.4%
Materials, % of revenue50.5%52.8%–51.9%54.0%58.0%55.1%54.6%46.3%49.0%
Employee costs, % of revenue13.5%12.9%–14.6%14.0%11.9%12.6%12.9%17.8%15.4%
Other expenses, % of revenue13.1%10.7%–10.0%8.2%7.2%7.4%7.5%7.9%8.3%
Depreciation and amortisation34–781015182124
Operating profit after depreciation78–12152018202945
Other income11–2125312
Finance costs33–2236898
Profit before one-off items and tax56–12131917162240
One-off items00–0000000
Profit before tax56–12131917162240
12–3344449
Net profit34–10111513121830
Other comprehensive income–––0000000
Total comprehensive income–––10111513121730
Net margin7.6%7.2%–11.6%11.3%11.9%9.6%7.6%9.9%12.1%

Balance sheet

Standalone, ₹ crore, at 31 March. The last column is the half year to Sep 2026, after the latest full year: the balance sheet at its end.

₹ croreMar 2023Filed 27 MayMar 2024Filed 21 MayMar 2025Filed 15 MayMar 2026Filed 12 MaySep 2026Half yearFiled 23 Oct
173262286325346
Share capital1922222222
Reserves154241264302324
11169755546
545963110120
10867674750
Total assets336389415481516
280317327341355
567289141161
Net debt10868755546
Borrowings are counted again inside the liabilities due within a year and after a year. Plant in use and plant being built are given for full years only. No balance sheet is on record for the years to Mar 2017, Mar 2018, Mar 2020, Mar 2021 and Mar 2022, so its lines and the ratios worked from it are blank there.

Cash flow

Standalone, ₹ crore, years to March. The last column is the half year to Sep 2026, after the latest full year: the cash flow over its six months.

₹ croreMar 2021Filed 1 JunMar 2022Filed 21 MayMar 2023Filed 27 MayMar 2024Filed 21 MayMar 2025Filed 15 MayMar 2026Filed 12 MaySep 2026Half yearFiled 23 Oct
14.635.833.324.535.649.323.5
15.335.637.627.638.053.325.0
−6.84.10.6−12.9−12.5−17.3−21.8
Receivables−4.1−1.8−7.91.1−9.8−19.410.6
Inventories−4.81.5−1.2−12.3−15.9−26.4−27.2
Payables2.610.8−4.41.4−6.430.510.7
Other working capital−0.5−6.414.2−3.119.6−1.9−16.0
Tax paid−0.70.2−4.3−3.2−2.4−4.0−1.5
Capital spending35.597.582.259.632.328.422.0
Free cash flow−21.0−61.7−48.9−35.13.320.91.4
Cash from investing−46.8−90.4−74.4−51.5−32.3−28.4−22.0
32.054.641.127.4−3.5−21.0−1.4
Dividends paid0.00.00.00.00.00.00.0
Shares bought back0.00.00.00.00.00.00.0
Shares issued7.910.133.477.47.78.60.0
Net change in cash−0.2−0.10.10.4−0.20.00.0
Capital spending is part of cash from investing, and dividends paid, shares bought back and shares issued are part of cash from financing. Each is shown as an amount on a line of its own, and the section's other items are in its total only. No cash flow statement is on record for the years to Mar 2017, Mar 2018 and Mar 2020.

Per share

Standalone, ₹ per share, years to March.

₹ per shareMar 2020Filed 24 AugMar 2021Filed 1 JunMar 2022Filed 21 MayMar 2023Filed 27 MayMar 2024Filed 21 MayMar 2025Filed 15 MayMar 2026Filed 12 May
Earnings per share₹6.40₹6.88₹17.54₹6.59₹5.64₹7.97₹13.70
Diluted earnings per share₹6.40₹6.88₹17.54₹6.59₹5.63₹7.95₹13.70
Book value per share–––₹91.09₹120.65₹130.10₹145.86
Shareholder yield–−4.7%−4.4%−8.7%−9.7%−1.7%−0.8%
Market cap at the year end (₹ crore)751692313828014651,109

Ratios

Standalone, years to March.Sakar Healthcare PE ratio and valuation

RatioMar 2017Mar 2018Mar 2019Mar 2020Filed 24 AugMar 2021Filed 1 JunMar 2022Filed 21 MayMar 2023Filed 27 MayMar 2024Filed 21 MayMar 2025Filed 15 MayMar 2026Filed 12 May
Revenue growth–20.2%––14.2%35.3%4.0%15.0%15.8%41.8%
Operating profit growth–23.9%––15.7%30.0%12.7%15.8%29.5%38.7%
Net profit growth–12.9%––11.1%42.6%−16.3%−8.5%50.0%74.2%
Earnings per share growth––––7.5%154.9%−62.4%−14.4%41.3%71.9%
––––––7.4%5.4%6.4%10.0%
–––––––−2.0 pts1.0 pts3.6 pts
From the net margin–––––––−1.5 pts1.6 pts1.5 pts
From asset turnover–––––––0.4 pts0.3 pts2.1 pts
From borrowing–––––––−0.9 pts−0.9 pts0.0 pts
Return on capital employed––––––6.4%6.1%8.0%11.9%
Cash conversion––––136.4%234.8%261.3%209.6%203.4%161.6%
Interest cover2.53.2–5.55.96.83.12.73.45.8
Debt to equity––––––0.640.260.260.17
Receivable days––––––60506373
Inventory days––––––76121193207
Payable days––––––12912093153
Cash conversion cycle, days––––––751163127
Working capital days––––––30629679
Asset turnover––––––0.400.420.440.56
Assets per rupee of net worth––––––1.941.661.471.47
Sales per rupee of plant––––––0.500.490.580.79
Capital spending to depreciation––––4.4110.095.483.301.551.20
Plant being built, % of plant in use––––––2.4%0.1%5.5%1.2%
No balance sheet is on record for the years to Mar 2017, Mar 2018, Mar 2020, Mar 2021 and Mar 2022, so its lines and the ratios worked from it are blank there.

Growth and returns over 3, 5 and 10 years

Standalone: the listed company alone, without its subsidiaries. Each window ends with the year to Mar 2026.

Return on assets, latest year
6.8%
Cash from operations against operating profit
71.5%
Measure10 years5 years3 years
Revenue growth, yearly rate–21.6%23.6%
Profit growth, yearly rate–23.3%33.7%
Return on equity, average–7.3%7.2%
Return on capital employed, average–8.1%8.7%
Operating margin, average24.7%25.6%26.8%
Net margin, average9.9%10.2%9.9%
Asset turnover, average–0.460.48
Cash conversion cycle, days, average–87114
Interest cover, average4.34.33.9
Debt to equity, average–0.330.23

Where the cash came from and went

Standalone: the listed company alone, without its subsidiaries. ₹ crore, added up over each window, which ends with the year to Mar 2026.

₹ crore5 years3 yearsLatest year
Cash from operations17810949
Cash from investing−277−112−28
Cash from financing993−21
Capital spending30012028
Dividends paid000
Shares bought back000
Shares issued for cash137949
Borrowings raised19200
Borrowings repaid1986722

Accounting checks

Standalone, years to March. Published tests of whether reported profit is backed by cash and the balance sheet.

CheckMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Effective tax ratePublished threshold 17.16 per cent29.9337.56–21.30––––––
A threshold marked as ours has no published figure; it is the line we read the check against.

Credit ratings

An agency's view of the chance the company repays a borrowing on time, from AAA, the highest, down to D, in default.

DateAgencyBorrowing ratedRatingOutlookAmount, ₹ Cr
22 Sep 2025ICRA Limited (opens in a new tab)Unallocated-Unallocated[ICRA]BBB /[ICRA]A3+Review, Re-affirmPositive10.82
22 Sep 2025ICRA Limited (opens in a new tab)Fund Based-Term Loan[ICRA]BBBReview, Re-affirmPositive68.18
22 Sep 2025ICRA Limited (opens in a new tab)Fund Based-Cash Credit[ICRA]BBBReview, Re-affirmPositive39
The latest rating on each borrowing. The agency's name opens its reasoning for the rating.